CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+33.15%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$400M
AUM Growth
+$400M
(+42%)
Cap. Flow
+$57.4M
Cap. Flow
% of AUM
14.36%
Top 10 Holdings %
Top 10 Hldgs %
66.54%
Holding
29
New
10
Increased
11
Reduced
5
Closed
3
Top Buys
| 1 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
$27.4M |
| 2 |
ENDP
Endo International plc
ENDP
|
$17.3M |
| 3 |
Biogen
BIIB
|
$14.4M |
| 4 |
INSY
Insys Therapeutics, Inc.
INSY
|
$14.3M |
| 5 |
Orthofix Medical
OFIX
|
$13.3M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$21.5M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$18.9M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$15.4M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$12M |
| 5 |
Vanda Pharmaceuticals
VNDA
|
$10.1M |
Sector Composition
| 1 | Healthcare | 49.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELGZ
26
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $111K | 0.03% | +13,770 | New | +$111K |
|
|
AMRN
27
Amarin Corp
AMRN
$311M
| – | – | -116,000 | Closed | -$673K |
|
|
28
Jazz Pharmaceuticals
JAZZ
$7.75B
| – | – | -312,858 | Closed | -$21.5M |
|
|
QCOR
29
DELISTED
QUESTCOR PHARMA INC
QCOR
| – | – | -200,000 | Closed | -$9.09M |
|